US 9956293
Targeted therapeutics
granted A61KA61K31/167A61K31/337
Quick answer
US patent 9956293 (Targeted therapeutics) held by Madrigal Pharmaceuticals, Inc. expires Mon Apr 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Madrigal Pharmaceuticals, Inc.
- Grant date
- Tue May 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/167, A61K31/337, A61K31/357, A61K31/4184